FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Hospital Universitario San Jorge de Pereira
Pereira, ColombiaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Jorge de Pereira (17)
2023
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2022
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
Joint Bone Spine, Vol. 88, Núm. 6
2016
-
Current concepts on microscopic colitis: Evidence-based statements and recommendations of the Spanish Microscopic Colitis Group
Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 3, pp. 400-426
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85
2007
-
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients
Journal of Acquired Immune Deficiency Syndromes, Vol. 45, Núm. 4, pp. 439-444
-
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
Journal of Viral Hepatitis, Vol. 14, Núm. 6, pp. 387-391
-
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin
Antiviral Therapy, Vol. 12, Núm. 4, pp. 469-476
-
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: The PRESCO trial
AIDS Research and Human Retroviruses, Vol. 23, Núm. 8, pp. 972-982
2005
-
Estudio multicéntrico de incidencia de las complicaciones de la nutrición enteral total en el paciente grave. Estudio ICOMEP 2
a
parte
Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 278-285
-
Estudio multicéntrico de incidencia de las complicaciones de la nutrición parenteral total en el paciente grave. Estudio ICOMEP 1
a
parte
Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 268-277
-
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C
Antiviral Therapy, Vol. 10, Núm. 5, pp. 657-662
-
Requerimientos de macronutrientes y micronutrientes
Nutricion Hospitalaria, Vol. 20, Núm. SUPPL. 2, pp. 13-17